Hemorragia adrenal bilateral en paciente recuperado de neumonía COVID-19 Grave. Caso Radiológico

Miranda, Roberto N.; Raurich, Rodrigo; Aris, Ricardo; Ramírez, Daniel; Hidalgo, Christian

doi:10.4067/s0034-98872021000701081

Cited by 4 publications

(2 citation statements)

References 6 publications

(11 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Our search identified a total of 25 cases of COVID‐19‐related AH (Figure 1). In particular, these included 9 cases of AH 8–17 and four cases of adrenal infarction 18–21 in the context of COVID‐19 infection. All four cases of adrenal infarction were bilateral, with no radiological features of haemorrhage, while 6/9 cases of AH were bilateral (66%) with three unilateral (2 left and 1 right sided).…”

Section: Resultsmentioning

confidence: 99%

“…Our search identified a total of 25 cases of COVID-19-related AH (Figure 1). In particular, these included 9 cases of AH [8][9][10][11][12][13][14][15][16][17] and four cases of adrenal infarction [18][19][20][21] UK-based patients from the systematic review, who were not captured through the survey resulting in a total of 18 cases (Figure 1). The details regarding the patient's demographic and clinical characteristics, the clinical presentation, and the outcome are reported in Tables 2-4, respectively.…”

Section: Overview Of the Literaturementioning

confidence: 99%

See 1 more Smart Citation

COVID‐19‐related adrenal haemorrhage: Multicentre UK experience and systematic review of the literature

Elhassan

Iqbal

Arlt

et al. 2023

Clinical Endocrinology

View full text Add to dashboard Cite

Objective: Adrenal haemorrhage (AH) is an uncommon, usually incidental imaging finding in acutely unwell patients. AH has been reported during coronavirus disease 2019 (COVID-19) infection and following ChAdOx1 nCoV-19 (Oxford-AstraZeneca) vaccination. The Society for Endocrinology (SfE) established a task force to describe the UK experience of COVID-19-related AH. Design: A systematic literature review was undertaken. A survey was conducted through the SfE clinical membership to identify patients with COVID-19-related AH using a standardized data collection tool. Results: The literature search yielded 25 cases of COVID-19-related AH (19 bilateral; 13 infection-related, and 12 vaccine-related). Eight UK centres responded to the survey with at least one case. A total of 18 cases were included in the descriptive study, including 11 from the survey and 7 UK-based patients from the systematic review. Seven patients (4 males; median age 53 (range 26-70) years), had infection-related AH (four bilateral). Median time from positive COVID-19 test to AH detection was 8 (range 1-30) days. Eleven cases of vaccine-related AH (eight bilateral) were captured (3 males; median age 47 (range 23-78) years). Median time between vaccination (nine Oxford-AstraZeneca and two Pfizer-BioNTech) and AH was 9 (range 2-27) days; 9/11 AH occurred after the first vaccine dose. Acute abdominal pain was the commonest presentation (72%) in AH of any cause. All 12 patients with bilateral AH and one patient with unilateral AH required glucocorticoid replacement. Conclusion: Adrenal haemorrhage with consequential adrenal insufficiency can be a complication of COVID-19 infection and vaccination. Adrenal function assessment is mandatory to avoid the potentially fatal consequences of unrecognized adrenal insufficiency.

show abstract

Section: Resultsmentioning

confidence: 99%